CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00245401

Enrollment

2070

Registered

2005-10-28

Start date

2003-08-31

Completion date

2004-12-31

Last updated

2007-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The purpose of this PMS registry, named e-CYPHER Stent Registry, is to collect post marketing surveillance data on the CYPHERTM Sirolimus-eluting Coronary Stent following marketing approval, when used in normal clinical practice within the labeled indications.

Interventions

DEVICECYPHERTM Sirolimus-Eluting Coronary Stent

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Cypher stent

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame
MACE at 30 days, 6 months and 1 year.	—

Secondary

Measure	Time frame
There is no pre-specified secondary outcome.	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026